Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 12, 2011, Pages 1250-1257

  Luo, Ming ^a   Li, Lei ^a   Lu, Chen Zheng ^b   Cao, Wu Kui ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Infection Disease Hospital   (China)

Author keywords

lactulose; meta analysis; minimal hepatic encephalopathy; treatment

Indexed keywords

AMMONIA; LACTULOSE; PLACEBO;

AMMONIA BLOOD LEVEL; ARTICLE; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ETHNIC DIFFERENCE; HEPATIC ENCEPHALOPATHY; HUMAN; INCIDENCE; META ANALYSIS; MINIMAL HEPATIC ENCEPHALOPATHY; MORTALITY; NEUROPSYCHOLOGICAL TEST; OVERT HEPATIC ENCEPHALOPATHY; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS;

ADULT; AMMONIA; DIARRHEA; DISEASE PROGRESSION; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 80955157383     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834d1938     Document Type: Article

References (37)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716-721. (Pubitemid 34183979)
2. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16:531-535. (Pubitemid 34188860)
3. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11:337-341.
4. Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United Statess: an AASLD survey. Hepatology 2007; 45:833-834. (Pubitemid 46450641)
5. Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomized trials. BMJ 2004; 328:1046-1052.
6. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 1999; 354:1896-1900.
7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12. (Pubitemid 26120810)
8. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26:1410-1414. (Pubitemid 27520004)
9. Horsmans Y, Solbreux PM, Daenens C, Desager JP, Geubel AP. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. Aliment Pharmacol Ther 1997; 11:165-170. (Pubitemid 27067349)
10. Li Z, Zhang H, Hong Y. Clinical effect of lactulose in the treatment of subclinical hepatic encephalopathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999; 9:13-15.
11. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000; 45:1549-1552.
12. Nie YQ, Zheng Z, Yu-yuan L, Sha WH, Ping L, Dai SJ. Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy. Zhonghua Nei Ke Za Zhi 2003; 42:261-266.
13. Xing Q, Liu L. Research of lactulose in the treatment of minimal hepatic encephalopathy. World Chinese Journal of Digestion 2003; 11:108-109.
14. Zeng Z, Li YY. Effect of lactulose treatment on the course of subclinical hepatic encephalopathy. Zhonghua Yi Xue Za Zhi 2003; 83:1126-1129.
15. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45:549-559. (Pubitemid 46450607)
16. Mittal VV, Sharma BC, Sharma P, Sarin SK A. randomized controlled trial comparing lactulose, probiotics and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2011; 23:725-732.
17. Romero-Gómez M, Boza F, Garćia-Valdecasas MS, Garćia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723.
18. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95:2029-2034.
19. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007; 13:1366-1371. (Pubitemid 47629568)
20. Bustamante J, Rimola A,Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895. (Pubitemid 29248991)
21. Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 1997; 53:930-942. (Pubitemid 27254571)
22. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24:556-560. (Pubitemid 26295997)
23. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol 1989; 84:156-159. (Pubitemid 19060750)
24. Kato A, Kato M, Ishii H, Ichimiya Y, Suzuki K, Kawasaki H, et al. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol Res 2004; 30:71-78. (Pubitemid 41115267)
25. Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Haussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007; 47:642-650. (Pubitemid 47503429)
26. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002; 22:190-197. (Pubitemid 34846356)
27. Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J Gastroenterol 2003; 22:37-41.
28. Edwing D, Flynn L, Klein A, Thuluvath PJ. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology 1999; 30:1363-1367.
29. Ham J, Gish RG, Mullen K. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy. Liver Transpl 2006; 12: 102-104.
30. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120:170-178. (Pubitemid 32061881)
31. Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011; 31:980-984.
32. Warren SE, Mitas JA II, Swerdlin AH. Hypernatremia in hepatic failure. JAMA 1980; 243:1257-1260. (Pubitemid 10130193)
33. Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; 103:1707-1715.
34. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39:1441-1449. (Pubitemid 38569067)
35. Bass NM, Ahmed A, Johnson L, Gardner JD. Rifaximin treatment is beneficial mild hepatic encephalopathy. Hepatology 2004; 40:646.
36. Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008; 20:506-511. (Pubitemid 351667890)
37. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29:1662-1667. (Pubitemid 29247036)